1.66
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kintara Therapeutics Inc | KTRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.66 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.66 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.65 | 1.70 | 0.05 | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.66 | USD |
Kintara Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 40.94M | 24.66M | 24.27M | $ - | $ - | -0.88 | -0.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Kintara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KTRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.50 | 1.78 | 1.34 | 1.56 | 1,045,425 | 0.16 | 10.67% |
| 1 Month | 1.36 | 1.78 | 1.26 | 1.46 | 512,430 | 0.30 | 22.06% |
| 3 Months | 1.36 | 1.80 | 1.18 | 1.45 | 427,331 | 0.30 | 22.06% |
| 6 Months | 1.21 | 1.95 | 1.00 | 1.47 | 443,308 | 0.45 | 37.19% |
| 1 Year | 1.21 | 1.95 | 1.00 | 1.47 | 443,308 | 0.45 | 37.19% |
| 3 Years | 1.21 | 1.95 | 1.00 | 1.47 | 443,308 | 0.45 | 37.19% |
| 5 Years | 1.21 | 1.95 | 1.00 | 1.47 | 443,308 | 0.45 | 37.19% |
Kintara Therapeutics Description
| Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. |
